- mmahomed2
Phase I SBIR grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases
Valitor, Inc. has been awarded a Phase I SBIR grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases. This project is designed to evaluate proof-of-concept for our multivalent protein conjugation technology to accelerate wound closure for patients who exhibit impaired wound healing associated with diabetes.